MGC Pharmaceuticals Limited
OTC: MGCLF0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Roby Reuven Zomer
- Headquarters
- West Perth, Australia
- IPO year
- 2017
- Market cap
- $12.1M
- Website
- https://mgcpharma.com.au
Loading MGCLF…
Loading profile data…Frequently asked questions about MGCLF
What does MGC Pharmaceuticals Limited (MGCLF) do?
MGC Pharmaceuticals Limited is a biopharmaceutical company dedicated to the global development and provision of plant-derived medicines. The firm manufactures and distributes both medical cannabis products and a range of non-cannabis botanical therapeutics. Among its key investigational drug candidates are CimetrA, which is undergoing Phase III...
Where does MGCLF trade?
MGC Pharmaceuticals Limited (MGCLF) trades on the Other OTC.
What sector is MGCLF in?
MGC Pharmaceuticals Limited (MGCLF) operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry.
Who is the CEO of MGC Pharmaceuticals Limited?
Roby Reuven Zomer is the chief executive officer of MGC Pharmaceuticals Limited (MGCLF).
Where is MGC Pharmaceuticals Limited headquartered?
MGC Pharmaceuticals Limited is headquartered in Australia.
Does MGCLF pay a dividend?
MGC Pharmaceuticals Limited (MGCLF) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did MGCLF go public?
MGC Pharmaceuticals Limited (MGCLF) completed its initial public offering in 2017.